#SVR

Antiviral therapy reduced the need for hospitalization and emergency treatment for liver-related and other conditions.

A four-drug combination cured all individuals who had experienced prior treatment failure.

Sofosbuvir-based regimens were well tolerated and cure rates were high in this population.

Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.

People treated for HCV were cured even without direct intervention from a specialist.

People with preexisting cognitive impairment saw greater improvement after successful treatment.

People who received a shortened course of antiviral therapy were less likely to be cured.

People under 50 who were cured of hepatitis C were at comparable risk to the general population.

Among people who inject drugs, integrating antiviral therapy with other care led to improved outcomes.

However, some 10% experienced liver decompensation even after antiviral therapy.

Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.

The risk was lower in people who had achieved a sustained virological response compared with those who had not.

Regardless of cirrhosis status, Mavyret led to high sustained virologic response rates in Latinos and other groups with hep C.

The struggle of mother’s day for a son and mother affected by Hepatitis C and vertical transmission, and what the future looks like.

Yep those are my cons resting up after a big week in Sydney. The red chairs of St Vincents Hospital are a welcome sight every time I go down

This is what it’s like to constantly live with the fear that hep C might come back. This is why it is we must embrace SVR as a cure, because...